The MedZilla Report: June 2008 Employment Outlook for Biotech/Pha...( Though the n...),Health

Though the number of jobs created in the medical field slowed in June, pharmaceutical companies reported a different kind of slowdown: they laid off fewer people in June than in previous months.

Seattle, WA (PRWEB) July 25, 2008 -- Though the number of jobs created in the medical field slowed in June overall, pharmaceutical companies reported a different kind of slowdown that will be music to the ears of sales representatives: fewer layoffs.

The largest share of downsizing reports for June came from hospital systems and medical centers. While most of them seemed to be cutting only a few jobs, often due to projected revenue outstripping actual revenue, Missouri and North Dakota medical facilities were both forced to release about 100 employees. Only a few pharmaceutical companies announced layoffs in June, most notably GlaxoSmithKline. GlaxoSmithKline's difficulties, as they have for many months, stem from the availability of generic drugs and the unwillingness to face U.S. regulators for new medications. However, other pharmaceutical groups such as Jazz Pharmaceuticals continue testing new drugs and have turned to stock sales to try and allay job cuts.

The fact that fewer pharmaceutical companies have laid off fewer employees in June than in months previous has not gone unnoticed by third-party job placement agencies. "Recruiters were hit pretty hard in the first quarter," said Michele Hopps, director of marketing for Medzilla.com, a leading career site for biotechnology, pharmaceuticals, health care, and science. "Some are finally making placements after not having made one since January." Hopps also noted that 15,000 new jobs were created in June, 13,000 of them in ambulatory health care, and that overall, 348,000 new jobs have been added in health care over the past year.

Two-thirds of the top 15 states for health care employment saw employers i
'/>"/>